OCA Acquisition Equity Warrant Exp 14 Jan 2026 *W EXP 01/31/2028
Change company Symbol lookup
Select an option...
OCAXW OCA Acquisition Equity Warrant Exp 14 Jan 2026 *W EXP 01/31/2028
ABBV Abbvie Inc
IIIN Insteel Industries Inc
KO Coca-Cola Co
MOD Modine Manufacturing Co
WABC Westamerica Bancorp
LUV Southwest Airlines Co
COF-K Capital One Financial Corp
NDAQ Nasdaq Inc
KEY-K KeyCorp
Go

Company profile

OCA Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company focuses to identify and acquire a United States business in the technology-enabled business services, including healthcare and education or financial services sectors. The Company has no operations and has no revenues.

Closing Price
$0.51
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
6,798
0

AbCellera to Report Third Quarter 2021 Financial Results on November 9, 2021

4:05 pm ET October 14, 2021 (BusinessWire) Print

AbCellera (Nasdaq: ABCL) will announce its third quarter 2021 financial results on Tuesday, November 9, 2021, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

The live webcast of the earnings conference will be available through a link that will be posted on AbCellera's Investor Relations website. A replay of the webcast will be available through the same link following the conference call.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. To learn more, visit www.abcellera.com.

Source: AbCellera Biologics Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211014006060/en/

SOURCE: AbCellera Biologics Inc.

Media: Jessica Yingling, Ph.D.; media@abcellera.com, +1(236)521-6774
Investor Relations: Melanie Solomon; ir@abcellera.com, +1(778)729-9116
comtex tracking

COMTEX_395213906/1006/2021-10-14T16:05:03

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.